The UFC’s first India-born fighter has been suspended for two years after testing positive for multiple performance-enhancers.

UFC anti-doping partner U.S. Anti-Doping Agency (USADA) today announced Bharat Kandare (5-3 MMA, 0-1 UFC), who hails from Maharashtra, India, accepted a two-year term after testing positive for a steroid and selective estrogen receptor modulator, or SERM.

Kandare, 31, failed an out-of-competition test conducted July 23, coming up positive for exogenous boldenone and its metabolites and a metabolite of tamoxifen. The former is a well-known steroid banned year round, while the latter is a breast cancer drug that also counteracts the effects of estrogen buildup from steroid use.

Kandare’s suspension is retroactive to Nov. 2, 2018, when he was provisionally suspended by USADA. The UFC changed its anti-doping agency earlier this year to not announce potential positives, instead holding an announcement until anti-doping cases are resolved.

The suspension brings Kandare’s octagon career to a swift halt after his debut in November 2017 ended in a first-round submission loss to Song Yadong (13-3 MMA, 3-0 UFC) at UFC Fight Night 122. Prior to that bout, another first-round submission on the international circuit snapped a five-fight win streak.

For complete coverage of UFC Fight Night 122, check out the UFC Events section of the site.